Mullin, A., and B. Jean-Claude. “HER2/Neu Oncogene and Sensitivity to the DNA-Interactive Drug Doxorubicin”. McGill Journal of Medicine, vol. 4, no. 1, Dec. 2020, doi:10.26443/mjm.v4i1.673.